Skip to content
Find an ETF
← All ETFs

Available in 10 markets

iShares U.S. Insurance ETF

iShares · US4642887867

iShares U.S. Insurance ETF is an exchange-traded fund (ETF) from iShares, traded under the ticker IAK (ISIN US4642887867). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well…

Equity ?Unknown Physical ?
Mid-range feeOwns the shares directlyUnited States
Find funds like this

Opens the screener with this filter applied.

Fund size (AUM) ?
€0
1-year return ?
+12.1%
Price Return · to 2026-07-23
Yearly fee (TER) ?
0.38%
All-in cost ≈ 0.00%

About this fund

How it works

The fund actually buys every share in the index it tracks (full replication).

Read more

Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.

Cost

0.38%Yearly fee (TER)
0.00%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Replication ?
Physical
Full — buys every share
Launched
May 2006
20-year track record

Performance

99.5101102103104202520252025

Growth of $100 invested — both lines start at $100.

iShares U.S. Insurance ETF Average peer fund (funds we track) ?

Compared with the average fund tracking the same index — our own data, not the licensed index itself.

YTD+6.6%
1 year+12.1%
3 years+16.9%
5 years+13.6%

Return, year by year

+9.4
+9.5
+26.3
+7.7
'22'23'24'25
4 of 4 up yearsBest: 2024 +26.3%Worst: 2025 +7.7%Calendar-year total returns, in USD

How bumpy has it been?

15.8%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-11.8%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.
1.01
Return for the risk (3y) ?
Reward earned per unit of bumpiness.

The bigger picture

+85.3%
Since inception
Total growth since launch — about +13.0% a year.
+44.2%
Best 12 months
The strongest one-year stretch on record.
-10.0%
Worst 12 months
The weakest one-year stretch on record.
-15.5%
Worst fall on record ?
It clawed back in about 2 months.

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
NYSEIAKUSD★ Primary
USD listings
E1IAKGBPUSD
E1IAKUSDUSD
EUIAKGBPUSD
EUIAKUSDUSD
MFIAK*USD
MMIAK*USD
MUIAK*USD
NYSE ArcaIAKUSD
OCIAKUSD
ODIAKUSD
TH3ISYUSD
UAIAKUSD
UBIAKUSD
UCIAKUSD
UDIAKUSD
UFIAKUSD
UMIAKUSD
USIAKUSD
UTIAKUSD
UXIAKUSD
VFIAKUSD
VGIAKUSD
VJIAKUSD
VKIAKUSD
VPIAKUSD
VYIAKUSD
X2IAKUSDUSD
XAIAKGBPUSD
XAIAKUSDUSD
XBIAKUSDUSD
XEIAKGBPUSD
XEIAKUSDUSD
XETRAIAKUSD
XFIAKGBPUSD
XFIAKUSDUSD
XGIAKGBPUSD
XGIAKUSDUSD
XHIAKUSDUSD
XHIAKGBPUSD
XJIAKGBPUSD
XJIAKUSDUSD
XLIAKGBPUSD
XLIAKUSDUSD
XOIAKUSDUSD
XOIAKGBPUSD
XQIAKGBPUSD
XQIAKUSDUSD
XSIAKGBPUSD
XSIAKUSDUSD
XUIAKGBPUSD
XUIAKUSDUSD
XVIAKUSDUSD
XVIAKGBPUSD
XWIAKGBPUSD
XWIAKUSDUSD
XXIAKGBPUSD
XXIAKUSDUSD
XZIAKGBPUSD
XZIAKUSDUSD
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 7% of similar ETFs📈 Higher 1-yr return than 27%📈 Higher 3-yr return than 55%📈 Higher 5-yr return than 93%📊 Behind its category by 5.3% (1-yr) (category average +17.4%)📊 Beat its category by 2.0% (3-yr) (category average +14.9%)📊 Beat its category by 5.0% (5-yr) (category average +8.5%)

Versus the Equity (stocks) · United States · USD ETFs we track.

Advanced risk

1.43
Sortino (3y) ?
1.43
Calmar (3y) ?
10.8%
Downside deviation ?
67%
Up months (hit rate) ?
$147.98
52-week high ?
$125.37
52-week low ?

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 United States stocks
Compare side by side
6 similar funds
iShares U.S. Insurance ETFiSharesYou're viewingState Street® SPDR® S&P 500® ETF TrustSPDRBroader matchiShares Core S&P 500 UCITS ETFiSharesBroader matchiShares Core S&P 500 UCITS ETFiSharesBroader matchState Street® SPDR® Portfolio S&P 500® ETFSPDRBroader matchiShares Core S&P 500 UCITS ETFiSharesBroader matchSchwab U.S. Dividend Equity ETFSchwabBroader match
Why it's similarThis is the fund on this page.
StocksUnknownPhysicalCheaper fee
StocksPhysicalCheaper fee
StocksPhysicalCheaper fee
StocksUnknownPhysicalCheaper fee
StocksPhysicalCheaper fee
StocksUnknownPhysicalCheaper fee
Index trackedS&P 500 IndexS&P 500S&P 500S&P 500 IndexS&P 500
Yearly fee (TER)0.38%0.09%0.10%0.10%0.02%0.07%0.06%
All-in cost0.00%0.00%0.10%0.00%0.00%0.07%0.00%
Fund size€0€682.6B€179.1B€154.3B€139B€134B€87.8B
DomicileUnited StatesIrelandIrelandUnited StatesIrelandUnited States
ReplicationPhysical (full)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+16.9%+17.4%+17.5%+17.4%+19.4%+10.2%
5-yr return p.a.+13.6%+11.0%+10.2%+11.0%+12.8%+5.5%
# holdings505511511508511103

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-07-23 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.